Markel–Vikkula–Mulliken syndrome

Markel–Vikkula–Mulliken syndrome is a rare genetic disorder characterized by a combination of vascular malformations and limb abnormalities. The syndrome is named after the researchers who first described it, highlighting its distinct clinical and genetic features. This article aims to provide a comprehensive overview of Markel–Vikkula–Mulliken syndrome, including its symptoms, causes, diagnosis, and treatment options.

Symptoms and Characteristics

Markel–Vikkula–Mulliken syndrome presents a range of symptoms primarily involving vascular malformations and limb overgrowth or undergrowth. The most common characteristics include:

• Vascular Malformations: Patients often exhibit capillary malformations that can vary in size and location. These are sometimes accompanied by more complex vascular anomalies such as lymphatic or arteriovenous malformations.
• Limb Abnormalities: The syndrome can cause overgrowth (macrodactyly) or undergrowth of limbs, leading to significant asymmetry. This can affect both the length and girth of the limbs.
• Soft Tissue Hypertrophy: Overgrowth of soft tissues in the affected limbs is common, contributing to the asymmetry and functional challenges.

Causes

Markel–Vikkula–Mulliken syndrome is a genetic disorder. It is believed to be caused by mutations in specific genes involved in the development and formation of blood vessels and limb development. However, the exact genetic mutations and their mechanisms are still under investigation. The condition is considered sporadic, occurring in individuals with no family history of the disorder.

Diagnosis

Diagnosis of Markel–Vikkula–Mulliken syndrome involves a comprehensive clinical evaluation and detailed medical history. Imaging studies such as MRI and ultrasound are crucial for assessing the extent of vascular and soft tissue abnormalities. Genetic testing may also be recommended to identify specific mutations, although this is not always conclusive.

Treatment

There is no cure for Markel–Vikkula–Mulliken syndrome, and treatment is symptomatic and supportive. Management strategies may include:

• Surgical Intervention: Surgery may be necessary to correct or reduce limb asymmetry and to address significant vascular malformations.
• Physical Therapy: Physical therapy is important for maintaining mobility and function in affected limbs.
• Pain Management: Pain associated with the syndrome can be significant and requires careful management.

Prognosis

The prognosis for individuals with Markel–Vikkula–Mulliken syndrome varies depending on the severity of the symptoms. With appropriate management, many individuals can lead active and fulfilling lives. However, ongoing medical care is often necessary to address the complex needs of these patients.

See Also

• Genetic Disorder
• Vascular Malformation
• Limb Overgrowth

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian